Molina Healthcare, Inc.
MOHNYSECIK 1179929FinancialsFiscal year ends Dec 31
Reports and events: 425 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2213:23 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001179929-26-000045 |
| 2026-10-2120:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001179929-26-000042 |
| 2026-07-2314:21 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001179929-26-000039 |
| 2026-07-2220:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001179929-26-000036 |
| 2026-06-1020:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-020160 |
| 2026-05-1113:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001179929-26-000026 |
| 2026-05-0813:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-015766 |
| 2026-04-2314:11 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001179929-26-000023 |
| 2026-04-2220:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001179929-26-000020 |
| 2026-03-2320:18 ET | DEF 14A | Proxy statementPeriod 2026-03-23 | 0001179929-26-000014 |
| 2026-02-2621:17 ET | 8-K | 7.01 Regulation FD disclosure | 0001437749-26-005871 |
| 2026-02-1021:18 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001179929-26-000005 |
| 2026-02-0622:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 2.06 Material impairments; 9.01 Financial statements and exhibits | 0001437749-26-003384 |
| 2026-02-0521:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001179929-26-000002 |
| 2025-11-2021:27 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-035866 |
| 2025-11-1823:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-035490 |
| 2025-11-1713:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-035305 |
| 2025-11-1421:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-035194 |
| 2025-10-2314:08 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001179929-25-000128 |
| 2025-10-2220:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001179929-25-000125 |
| 2025-08-1220:16 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001437749-25-026208 |
| 2025-07-2413:49 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001179929-25-000119 |
| 2025-07-2320:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001179929-25-000116 |
| 2025-07-0710:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-022210 |
| 2025-05-0120:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001179929-25-000075 |
| 2025-04-2414:04 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001179929-25-000070 |
| 2025-04-2320:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001179929-25-000067 |
| 2025-03-1820:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-008247 |
| 2025-03-1720:18 ET | DEF 14A | Proxy statementPeriod 2025-03-17 | 0001179929-25-000043 |
| 2025-02-2121:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001437749-25-004747 |
| 2025-02-1121:08 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001179929-25-000023 |
| 2025-02-0521:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001179929-25-000020 |
| 2025-02-0321:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-002597 |
| 2024-12-1622:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-037651 |
| 2024-11-1821:20 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-035619 |
| 2024-11-1322:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-034962 |
| 2024-11-1314:16 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-034694 |
| 2024-11-1221:17 ET | 8-K | 8.01 Other events | 0001437749-24-034559 |
| 2024-11-0814:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-034075 |
| 2024-10-2414:34 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001179929-24-000151 |
| 2024-10-2320:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001179929-24-000148 |
| 2024-10-1713:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-24-031432 |
| 2024-10-1620:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-031357 |
| 2024-09-2313:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001437749-24-029806 |
| 2024-08-2013:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-24-027304 |
| 2024-07-2515:38 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001179929-24-000123 |
| 2024-07-2420:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001179929-24-000120 |
| 2024-05-0320:15 ET | 8-K | 5.07 Shareholder vote results | 0001179929-24-000091 |
| 2024-04-2513:40 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001179929-24-000089 |
| 2024-04-2420:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001179929-24-000086 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.